SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Dong-A ST Wins Korean Approval for Type 2 Diabetes Combination Drug

South Korea’s Ministry of Food and Drug Safety approved Dong-A ST’s Sugaremfa combination drug for type 2 diabetes on October 30, 2026.

Related stories